Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women
NCT05264662Phase 4Completed
- Start
- Mar 2022
- Primary completion
- Mar 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of acellular pertussis vaccine in pertussis. Started Mar 2022; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on NCT05264662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05264662.